MedPath

Comparisian of local treatment by triamcinolon orabase with curcumin orabase in oral Graft-versus-host reaction or disease

Not Applicable
Conditions
Graft-versus-host reaction or disease.
Graft-versus-host reaction or disease
Registration Number
IRCT201508173144N5
Lead Sponsor
Vice chancellor for research, Faculty of Dentistry, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
26
Inclusion Criteria

being a patient with Oral Graft-versus-host reaction or disease. Exclusion criteria: taking another medication.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lcer pain. Timepoint: One week after intervention. Method of measurement: Visual Analogue Scale (VAS).;Ulcer size. Timepoint: One week after intervention. Method of measurement: Kolis.
Secondary Outcome Measures
NameTimeMethod
lcer healing. Timepoint: One week after intervention. Method of measurement: Clinical examination.
© Copyright 2025. All Rights Reserved by MedPath